Company Zalicus Inc Nasdaq
Equities
US98887C1053
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Business Summary
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 26,184,349 | 26,184,349 ( 100.00 %) | 0 | 100.00 % |
Company contact information
EPIRUS Biopharmaceuticals, Inc.
699 Boylston Street 8th floor
02116, Boston
+617-600-3497
![address Zalicus Inc](https://cdn.zonebourse.com/static/address/6605801.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+38.65% | 39.1B | |
-9.17% | 38.76B | |
+27.23% | 31.24B | |
+10.74% | 25.9B | |
-13.50% | 25.8B | |
+43.83% | 14.06B | |
+34.49% | 13.12B | |
-8.16% | 11.32B | |
-13.22% | 10.68B |
- Stock Market
- Equities
- EPRSQ Stock
- Stock
- Company Zalicus Inc